Resource preview:
Pharmacokinetics (PK) and toxicokinetics (TK) are essential preclinical studies needed to inform clinical tests’ dosing levels for safety and efficacy. Without a thoughtful PK/TK package within a complete investigational new drug (IND) application, promising drug candidates never advance to patients.

In this briefing report you'll access:
- Tips to prioritize coordination and collaboration between teams
- Attributes of successful PK/TK studies
- Cautionary tales
- Questions to ask while developing your PK/TK study

Please complete the form below in order to access our resource:

"*" indicates required fields